We invest billions to develop new drugs for cardiovascular disease, type 2 diabetes, cancer, etc. but little to address the reasons they became common in the first place.
We invest massively in developing and evaluating the effectiveness of bariatric surgery, but spend orders of magnitude less on public health and policy interventions to reduce obesity.
An explosion of new inhalers for asthma and chronic obstructive pulmonary disease have appeared over the past 20 years. Yet we have invested almost nothing in reducing air pollution or climate crisis induced wildfires, both of which produce detectable effects on rates of hospitalisation and even all cause mortality
Bookmarks